The effect of radiosensitizers on radio‐immunotherapy, using 131I‐Labelled anti‐cea antibodies in a human colonic xenograft model

International Journal of Cancer

Volumn 47, Issue 4, 1991, Pages 597-602

  Barbara Pedley, R ^a   Begent, Richard H J ^a   Boden, Joan A ^a   Boden, Robert ^a   Adam, Theresa ^a   Bagshawe, Kenneth D ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; IDOXURIDINE; IODINE 131; MISONIDAZOLE; MONOCLONAL ANTIBODY; RADIOSENSITIZING AGENT;

ANIMAL EXPERIMENT; ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; TUMOR XENOGRAFT;

ANIMAL; ANTIBODIES, MONOCLONAL; CARCINOEMBRYONIC ANTIGEN; COLONIC NEOPLASMS; HUMAN; IDOXURIDINE; IODINE RADIOISOTOPES; METABOLIC CLEARANCE RATE; MICE; MISONIDAZOLE; NEOPLASM TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0025963806     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910470420     Document Type: Article

References (33)

1. Hypoxic cell radiosensitizers for radiotherapy
2. Radiation sensitization and chemopotentiation: RSU‐1069, a compound more efficient than misonidazole in vitro and in vivo
3. Use of second antibody in radioimmunotherapy
4. 2 fragments
5. 131I‐labelled monoclonal anti‐CEA antibodies in a nude mouse model
6. l31I‐radiolabeled disialoganglioside GD2‐specific monoclonal antibody against human neuroblastoma xenografted in nude mice
7. 125‐labelled iododeoxyuridine into the deoxyribonucleic acid of murine and human tissues following therapeutic doses
8. Testing of hypoxic cell sensitizers in vitro
9. Chemical sensitizers for hypoxic cells: a decade of experience in clinical radiotherapy
10. Genetics of human cell lines. III. Incorporation of 5‐bromo and 5‐iododeoxyuridine into the deoxyribonucleic acid of human cells and its effect on radiation sensitivity
11. DNA damage induced by reductively activated nitroimidazoles‐pH effects
12. The effects of misonidozole during continuous low‐dose‐rate irradiation
13. Cytotoxic effect of misonidazole and cyclophosphamide on aerobic and hypoxic cells in a C3H mammary carcinoma in vivo
14. Radiosensitization of brain tumors
15. The use of halogenated thymidine analogs as clinical radiosensitizers: rationale, current status, and future prospects: non‐hypoxic cell sensitizers
16. A computer program for comparing K samples with right‐censored data
17. A mathematical evaluation of tumour growth curves in rapid, intermediate and slow growing rat hepatoma
18. Radiation response of mammalian cells grown in culture. III. Modification of X‐ray survival of Chinese hamster cells by 5‐bromodeoxyuridine
19. 131‐iodine‐conjugated antibody cell kill enhanced by bromodeoxyuridine
20. Effect of radiosensitizers on radioimmunotherapy using anti‐CEA antibodies in a colonic tumour xenograft model
21. Relationship between tumour size and uptake of radiolabeled anti‐CEA antibody in a colon tumour xenograft
22. The effect of second antibody clearance on the distribution and dosimetry of radiolabelled anti‐CEA antibody in a human colonic tumour xenograft model
23. 131I in spontaneous C3H mouse mammary tumours
24. Therapeutic attack of hypoxic cells of solid tumours
25. Distribution of intact and Fab'2 fragments of anti‐human chorionic gonadotrophin antibodies in nude mice bearing human choriocarcinoma xenografts
26. 131I‐labeled murine monoclonal antibody to carcinoembryonic antigen
27. The toxicity of the radiosensitizer misonidazole towards hypoxic cells in vitro: a model for mouse and man
28. The interaction of misonidazole with radiation, chemotherapeutic agents, or heat
29. Effect of radiation sensitizing agents in radiation therapy of mouse mammary carcinoma
30. Addition of misonidazole, etanidazole, or hypothermia to treatment with fluosol‐DA/carbogen/radiation
31. Human colonic adenocarcinoma cells. 1. Establishment and description of a new cell line
32. An investigation of the possibility of chemosensitization by clinically achievable concentrations of misonidazole
33. 131I‐labeled monoclonal antibodies